Broderick Brian C Eli Lilly & CO Transaction History

Broderick Brian C

$470 Million
Q3 2024

A detailed history of Broderick Brian C transactions in Eli Lilly & CO stock. As of the latest transaction made, Broderick Brian C holds 2,728 shares of LLY stock, worth $2.15 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

2,728

Previous 2,752 0.87%

Holding current value

$2.15 Million

Previous $2.49 Million 3.01%

% of portfolio

0.51%

Previous 0.55%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $18,531 - $23,040	-24 Reduced 0.87%	2,728 $2.42 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $150,048 - $188,171	207 Added 8.13%	2,752 $2.49 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $1.51 Million - $2.02 Million	2,545 New	2,545 $1.98 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $293,878 - $364,705	-1,307 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $11,080 - $13,635	-50 Reduced 3.68%	1,307 $303,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $73,944 - $95,724	-450 Reduced 24.9%	1,357 $253,000
Q3 2020 Oct 28, 2020	SELL	$146.22 - $169.13 $18,277 - $21,141	-125 Reduced 6.47%	1,807 $267,000
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $14,881 - $18,418	-125 Reduced 6.08%	1,932 $268,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $24,927 - $29,097	-225 Reduced 9.86%	2,057 $228,000
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $63,001 - $74,157	-566 Reduced 19.87%	2,282 $296,000
Q4 2018 Jan 24, 2019	SELL	$105.9 - $118.64 $137,670 - $154,232	-1,300 Reduced 31.34%	2,848 $330,000
Q3 2018 Oct 15, 2018	SELL	$85.86 - $107.31 $81,567 - $101,944	-950 Reduced 18.63%	4,148 $446,000
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $302,440 - $324,401	-3,691 Reduced 42.0%	5,098 $431,000
Q3 2017 Oct 26, 2017	BUY	$77.07 - $85.54 $677,368 - $751,811	8,789	8,789 $752,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.

Account

Broderick Brian C Eli Lilly & CO Transaction History